These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 6883380

  • 1. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
    Björklund V, Björklund B.
    Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
    [Abstract] [Full Text] [Related]

  • 2. Immuno-histochemical localization of tissue polypeptide antigen (TPA) and carcino-embryonic antigen (CEA) in breast cancer. A comparative study.
    Björklund V, Björklund B, Wittekind C, von Kleist S.
    Acta Pathol Microbiol Immunol Scand A; 1982 Nov; 90(6):471-6. PubMed ID: 6187181
    [Abstract] [Full Text] [Related]

  • 3. Human tissue polypeptide antigen in breast cancer.
    Nemoto T, Constantine R, Chu TM.
    J Natl Cancer Inst; 1979 Dec; 63(6):1347-50. PubMed ID: 292806
    [Abstract] [Full Text] [Related]

  • 4. Tissue polypeptide antigen and carcinoembryonic antigen in colon tumors: serum levels and immunohistochemical localization.
    Bombardieri E, Jotti GS, Cocciolo MG, Mori M, Rusconi A, Rusca M, Seregni E, Becchi G, Fontanesi M, Tardini A.
    Cancer Detect Prev; 1985 Dec; 8(1-2):219-26. PubMed ID: 4064041
    [Abstract] [Full Text] [Related]

  • 5. Combined use of carcinoembryonic antigen and tissue polypeptide antigen in oncologic therapy and surveillance.
    Lüthgens M, Schlegel G.
    Cancer Detect Prev; 1983 Dec; 6(1-2):51-9. PubMed ID: 6883393
    [Abstract] [Full Text] [Related]

  • 6. Significance of carcinoembryonic and tissue polypeptide antigen determination in the diagnosis of metastases in breast cancer.
    Kausitz J, Hupka S, Makaiová I, Michalíková B, Urbanová M, Bohunický L, Belovicová C.
    Neoplasma; 1986 Dec; 33(4):471-6. PubMed ID: 3762808
    [Abstract] [Full Text] [Related]

  • 7. [Tissue polypeptide and carcinoembryonic antigens in patients with breast cancer].
    Polevaia EB, Tkacheva GA, Ivanov VM, Koposova TL.
    Vopr Onkol; 1984 Dec; 30(3):9-13. PubMed ID: 6710954
    [Abstract] [Full Text] [Related]

  • 8. Expression of tumour markers CA50, CEA and TPA in female breast carcinoma as related to histopathological findings and survival.
    Eskelinen M, Lipponen P, Syrjänen K.
    Anticancer Res; 1992 Dec; 12(1):91-5. PubMed ID: 1567186
    [Abstract] [Full Text] [Related]

  • 9. [The tumor markers TPA and CEA in the after care of breast cancer].
    Beaufort F, Fueger GF, Steiner H.
    Wien Med Wochenschr; 1985 Feb 28; 135(4):85-8. PubMed ID: 2986366
    [Abstract] [Full Text] [Related]

  • 10. [Distribution and prognostic value of CEA and TPA in cancer of the lung].
    Leonardo E, Dogliotti C, Mancuso M, Sanfilippo B, Oliaro A.
    Minerva Med; 1986 Mar 17; 77(11):375-9. PubMed ID: 3703330
    [Abstract] [Full Text] [Related]

  • 11. Comparison between tissue antigen analysis and plasma determinations for TPA and CEA in transitional cell carcinomas and in tumorfree urothelium of the urinary bladder.
    Vogel J, Oehr P, Maisey R, Adolphs HD.
    Cancer Detect Prev; 1988 Mar 17; 11(3-6):389-96. PubMed ID: 2455597
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Tozuka K, Yonese Y, Nakagami Y, Minowa T, Hiraoka Y, Yamada N, Hikima N, Ishii Y, Tannowa K, Fujioka Y.
    Gan To Kagaku Ryoho; 1984 May 17; 11(5):1078-83. PubMed ID: 6721513
    [Abstract] [Full Text] [Related]

  • 13. [A comparative evaluation of tumor markers (TPA and CEA) in various malignant neoplasms at an advanced stage].
    Meregalli M, Antoniazzi V, Torchio G, Colombo E, Bocchi M, Sonzini E, Lino S.
    Minerva Med; 1989 Apr 17; 80(4):345-7. PubMed ID: 2725935
    [Abstract] [Full Text] [Related]

  • 14. [CEA and TPA in cancer of the breast. Findings and criteria of use].
    Torres Avisbal M, Ruíz de Almodovar Rivera JM, Villalba Moreno J, Olea Serrano N, Padilla Bolivar O, Pedraza Muriel V.
    Rev Esp Oncol; 1985 Apr 17; 32(2):265-80. PubMed ID: 3843460
    [Abstract] [Full Text] [Related]

  • 15. [Ferritin, CEA and TPA as tumor markers in breast neoplasms].
    Bonanni F, Folco U, Giudici Cipriani A, Buffa E, Amedeo A, Bertolotto M, Rembado R, Barbetti V, Guglieri F.
    Minerva Med; 1985 Sep 15; 76(34-35):1533-4. PubMed ID: 4034052
    [Abstract] [Full Text] [Related]

  • 16. [Importance of the tissue polypeptide antigen level in neoplastic patients. Its correlation with other tumor markers].
    Ruibal A, Durán P, Lafuerza A, Bodi R, Solé LA, Rubio D, Ibarz L, De Torres JA, Domenech-Torné FM, Salvador L.
    Rev Esp Oncol; 1984 Sep 15; 31(3):409-14. PubMed ID: 6546169
    [Abstract] [Full Text] [Related]

  • 17. [Clinical evaluation of tumor markers in breast cancer patients].
    Ito T, Tanaka S, Ban K, Sakai N, Oshita H, Oiwa T, Kanno A, Kashizuka T.
    Gan To Kagaku Ryoho; 1987 Oct 15; 14(10):2917-23. PubMed ID: 3310907
    [Abstract] [Full Text] [Related]

  • 18. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.
    Paulick R, Caffier H, Paulick M.
    Cancer Detect Prev; 1987 Oct 15; 10(3-4):197-203. PubMed ID: 3568016
    [Abstract] [Full Text] [Related]

  • 19. [Clinical study of the measurement of tissue polypeptide antigen in patients with breast cancer].
    Fukunaga M, Otsuka N, Yanagi M, Sone T, Muranaka A, Yanagimoto S, Tomomitsu T, Morita R, Ohama T, Sonoo H.
    Gan No Rinsho; 1985 Jul 15; 31(8):923-8. PubMed ID: 4032770
    [Abstract] [Full Text] [Related]

  • 20. Plasma carcinoembryonic antigen and tissue polypeptide antigen levels in lung cancer: correlation with cell types and stage.
    Salvati F, Antilli A, Cruciani AR, Pau F, Flore F, Munno R, De Angelis G, Cipri A, Pigorini F.
    Cancer Detect Prev; 1985 Jul 15; 8(1-2):111-4. PubMed ID: 4064030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.